reimbursements news from FierceHealthcare
News
California MD groups get $65M in P4P bonuses
Medical practices get the squeeze in '08
AMA opposes revision of Medicare bill
Stryker, former division settle false claims allegations
Aetna limits anemia drug payments
Despite fears, Medicare cuts didn't harm cancer care
ALSO NOTED: Highmark questions cardiac surgery reimbursement report; Indiana examines never events; and much more...
AMA fights physician Medicare cuts
The American Medical Association has begun its latest no-holds-barred campaign to make Congress cancel a scheduled Medicare reimbursement cut. As part of its campaign, AMA is publicizing the results of its survey of 9,000 physicians, which found that more than half would to limit the number of Medicare patients they accept if the planned 10 percent cut is implemented. (Sure, there's a bit of grandstanding going on here--but the pain is real, too.) Patients aren't the only ones who would …
Read more...MD groups seek new Medicare rate formula
The current system Medicare used to gradually bump up reimbursement rates for physicians isn't fair, and should be replaced by one which takes physician practice costs into account, a group of 87 medical organizations told Congress. The group, which includes the American Medical Association, notes that hospitals and nursing homes are paid based on their costs. However, physicians are paid based on a formula known as the sustainable growth rate (SGR), tied to the U.S. economy, which has …
Read more...Doctors protest low Gardasil reimbursements
While many public health officials are excited about the Gardasil's potential to prevent cervical cancer, doctors are increasingly refusing to offer it to patients--including the pediatricians and gynecologists who are its most likely prescribers. These doctors say that reimbursements for the expensive vaccine are not high enough to justify the stocking and administrative costs of carrying it. For example, some insurance companies are reimbursing doctors $122 per shot, or just $2 more …
Read more...Get more reimbursements coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




